Evidence map›Paper›PMID 27617390›Full record

ArticleNature methods2016

An in vivo multiplexed small-molecule screening platform.

Barbara M Grüner, Christopher J Schulze, Dian Yang, Daisuke Ogasawara, Melissa M Dix, Zoë N Rogers, Chen-Hua Chuang, Christopher D McFarland, Shin-Heng Chiou, J Mark Brown and 3 more

Open access · greenAbstract read
In one paragraph

Article in Nature methods, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Advances in covalent drug discovery.Nature reviews. Drug discovery · 2022
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Barbara M Grüner *Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
Christopher J Schulze *Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Dian YangCancer Biology Program, Stanford University School of Medicine, Stanford, CA, USA.
Daisuke OgasawaraDepartment of Chemical Physiology, The Scripps Research Institute, La Jolla, CA, USA.
Melissa M DixDepartment of Chemical Physiology, The Scripps Research Institute, La Jolla, CA, USA.
Zoë N RogersDepartment of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
Chen-Hua ChuangDepartment of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
Christopher D McFarlandDepartment of Biology, Stanford University, Stanford, CA, USA.
Shin-Heng ChiouDepartment of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
J Mark BrownDepartment of Cellular and Molecular Medicine, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA.
Benjamin F CravattDepartment of Chemical Physiology, The Scripps Research Institute, La Jolla, CA, USA.
Matthew BogyoDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Monte M WinslowDepartment of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
Stanford University · USScripps Research Institute · USCleveland Clinic Lerner College of Medicine · US

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Melinda L. Telli · 2007 to 2026
$71.4M
CHEMOPROTEOMIC METHODS FOR SERINE HYDROLASE INHIBITOR DEVELOPMENTR01DA033760 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI CRAVATT, BENJAMIN F, SCAMPAVIA, LOUIS DANIEL · 2012 to 2021
$5.1M
Chemical Probes for Metabolic Pathway Discovery in Human DiseaseR01CA132630 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI CRAVATT, BENJAMIN F · 2007 to 2018
$5.1M
Cancer Systems Biology Scholars ProgramR25CA180993 · NCI · STANFORD UNIVERSITY · PI PLEVRITIS, SYLVIA KATINA · 2014 to 2018
$2.2M
Enzymatic Control of Trimethylamineoxide (TMAO)Induced AtherosclerosisR01HL122283 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI BROWN, JONATHAN MARK · 2014 to 2018
$2.0M
Multiplexed in vivo drug screening: Inhibitors of metastatic seedingR21CA188863 · NCI · STANFORD UNIVERSITY · PI BOGYO, MATTHEW, WINSLOW, MONTE MEIER · 2014 to 2015
$385k
Chemical genetic investigation of metastatic seeding in pancreatic ductal adenocarcinoma using novel multiplexed in vivo screeningF32CA200078 · NCI · STANFORD UNIVERSITY · PI SCHULZE, CHRISTOPHER JAMES · 2016 to 2017
$61k
NCI NIH HHS F32 CA200078NCI NIH HHS P30 CA124435NCI NIH HHS R01 CA132630NCI NIH HHS R21 CA188863NCI NIH HHS R25 CA180993NHLBI NIH HHS R01 HL122283NIDA NIH HHS R01 DA033760
6 · The paper itself

Abstract

Phenotype-based small-molecule screening is a powerful method to identify molecules that regulate cellular functions. However, such screens are generally performed in vitro under conditions that do not necessarily model complex physiological conditions or disease states. Here, we use molecular cell barcoding to enable direct in vivo phenotypic screening of small-molecule libraries. The multiplexed nature of this approach allows rapid in vivo analysis of hundreds to thousands of compounds. Using this platform, we screened >700 covalent inhibitors directed toward hydrolases for their effect on pancreatic cancer metastatic seeding. We identified multiple hits and confirmed the relevant target of one compound as the lipase ABHD6. Pharmacological and genetic studies confirmed the role of this enzyme as a regulator of metastatic fitness. Our results highlight the applicability of this multiplexed screening platform for investigating complex processes in vivo.

Indexed as

AnimalsCell AdhesionCell Line, TumorCell MovementCell ProliferationDose-Response Relationship, DrugDrug Evaluation, PreclinicalGene Knockdown TechniquesHigh-Throughput Screening AssaysHumansLiver NeoplasmsMiceMice, SCIDMolecular ImagingMonoacylglycerol LipasesNeoplasm TransplantationABHD6 protein, humanABHD6 protein, mouseMonoacylglycerol LipasesSmall Molecule Libraries

Identifiers

PMID27617390
PMCPMC5088491
OpenAlexW2519825823

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.